1 Day
Source:
Irish Independent
_1777370220974_847775619.png&w=48&q=75){kind=small}
Luke O’Neill: Friedreich’s ataxia drug not a cure, but promising
NCPE has advised not to fund the treatment due to its high cost relative to the limited benefits it offers.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)